Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Defense & Aerospace

Honeywell’s Dividend Dilemma: A Mixed Blessing for Shareholders

Felix Baarz by Felix Baarz
November 14, 2025
in Defense & Aerospace, Dividends, Earnings, Industrial
0
Honeywell Stock
0
SHARES
118
VIEWS
Share on FacebookShare on Twitter

Industrial powerhouse Honeywell International has announced an increased dividend payout, creating an interesting scenario for investors. While long-term shareholders celebrate enhanced returns, those buying shares now will miss the upcoming distribution. This development comes amid strong quarterly performance and record order levels, raising questions about the stock’s near-term trajectory.

Strong Quarterly Performance Sets Stage

The company’s third-quarter 2025 financial results exceeded even the most optimistic projections. Revenue reached $10.4 billion, with adjusted earnings per share coming in at $2.82, significantly surpassing the company’s own forecasts. More impressively, new orders surged by 22 percent, driving the order backlog to an unprecedented $39.1 billion.

This robust operational performance provided the foundation for the board’s decision to raise the quarterly dividend by 6 cents to $1.19 per share. This marks the fourteenth consecutive year of dividend increases, demonstrating Honeywell’s commitment to returning value to shareholders.

The Ex-Dividdate Reality Check

Honeywell shares began trading ex-dividend today, meaning only shareholders who held the stock through yesterday’s session will qualify for the next payment scheduled for December 5. New investors purchasing shares from today forward will not receive this distribution—a standard market mechanism that typically results in minor price adjustments.

Should investors sell immediately? Or is it worth buying Honeywell?

With the company boasting a market capitalization of approximately $132 billion, the current dividend yield stands at an attractive 2.4 percent, positioning Honeywell as particularly appealing for income-focused investors seeking financial stability.

Revised Outlook and Future Prospects

Following the stronger-than-expected quarterly results, Honeywell has raised its full-year 2025 guidance. The corporation now anticipates revenue between $40.7 and $40.9 billion, with adjusted earnings per share projected in the range of $10.60 to $10.70.

The central question facing market participants is whether the current operational strength can provide sustained momentum for the share price. Despite solid fundamental metrics, some wonder if Honeywell remains primarily a value investment with limited appreciation potential. Market watchers suggest the next quarterly report in January may provide clearer direction regarding the company’s growth trajectory.

Ad

Honeywell Stock: Buy or Sell?! New Honeywell Analysis from February 7 delivers the answer:

The latest Honeywell figures speak for themselves: Urgent action needed for Honeywell investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Honeywell: Buy or sell? Read more here...

Tags: Honeywell
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
TSMC Stock

TSMC's Multi-Billion Dollar Bet on Artificial Intelligence

Sealed Air Stock

Sealed Air Shares Surge on Acquisition Speculation

Conagra Brands Stock

Can Conagra Brands Stock Recover From Its Steep Decline?

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com